The Claim
Daily administration of 10 mg melatonin for 24 weeks significantly improves disease-specific health-related quality of life in patients with stable heart failure with reduced ejection fraction compared to placebo.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 10 mg of melatonin every day for six months helps heart failure patients feel better and live more comfortably, according to a study comparing it to a placebo.
See the scientific wording
Daily administration of 10 mg melatonin for 24 weeks significantly improves disease-specific health-related quality of life in patients with stable heart failure with reduced ejection fraction, as measured by a mean improvement of 5.8 points on the Minnesota Living with Heart Failure Questionnaire compared to placebo, demonstrating meaningful symptomatic relief.
What the research says
1 studyThe RCT utilized the validated Minnesota Living with Heart Failure Questionnaire to assess quality of life. The statistically significant difference in favor of the melatonin group demonstrates a direct causal benefit of the intervention on patient-reported outcomes, highlighting its capacity to alleviate the daily physical and emotional burden of heart failure.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.